CSX vs STRO
CSX Corporation (CSX) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
CSX Corporation (CSX) is a railroads company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported CSX revenue for 2025-12-31 was $14.09B. Net income was $2.89B. Revenue was down 3.1% from 2024-12-31 to 2025-12-31. CSX currently screens at market cap $61.18B and trailing P/E 19.4.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
CSX currently screens at market cap $61.18B and trailing P/E 19.4. STRO currently screens at market cap $470.8M.
Not investment advice. Open the CSX and STRO stock pages for the full models.
Not investment advice.